We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current RAC market cap is 218.5M. The company's latest EPS is AUD -0.0586 and P/E is -22.01.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 229k | 256k | 425k | 708k | 3.13M |
| Operating Income | -3.68M | -3.86M | -6.36M | -11.26M | -10.52M |
| Net Income | -3.66M | -3.85M | -6.34M | -11.2M | -9.92M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 5.24M | 5.93M | 14.25M | 37.53M | 26.64M |
| Total Liabilities | 192k | 244k | 524k | 1.42M | 1.15M |
| Total Equity | 5.05M | 5.69M | 13.72M | 36.11M | 25.49M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -2.67M | -2.46M | -4.7M | -6.26M | -10.65M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | -34k | 3.21M | 12.28M | 30.52M | -1.28M |
| Market Cap | 218.5M |
| Price to Earnings Ratio | -22.01 |
| Price to Sales Ratio | 69.73 |
| Price to Cash Ratio | 10.15 |
| Price to Book Ratio | 8.57 |
| Dividend Yield | - |
| Shares Outstanding | 169.38M |
| Average Volume (1 week) | 103.46k |
| Average Volume (1 Month) | 134.13k |
| 52 Week Change | -32.64% |
| 52 Week High | 1.97 |
| 52 Week Low | 0.64 |
| Spread (Intraday) | 0.06 (4.44%) |
| Company Name | Race Oncology Ltd |
| Address |
level 36 sydney, new south wales 2000 |
| Website | https://www.raceoncology.com |
| Industry | drug & proprietary stores (5912) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
